| | Update on board meeting | 25/01/23 16:06 | Board Meeting |  |
| | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 ,inter alia, to consider and approve Further to the intimation dated 11th January, 2023 regarding the Meeting of the Board of Directors of Astec LifeSciences Limited ('the Company') scheduled to be held on Monday, 30th January, 2023 to, inter alia, consider and approve the Standalone and Consolidated Unaudited Financial .... | |
| |
| | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | 31/10/22 19:05 | Company Update | |
| | Please note that the Audio Recording of Conference call of Astec LifeSciences Limited with the Investors and Analysts held today i.e. on Monday, October 31, 2022, is available / accessible at the website of the Company.
Kindly take the same on your records. | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 29/10/22 17:01 | Company Update | |
| | Pursuant to Regulation 30 read with Schedule III and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper publication of the Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2022, published by the Company today, i.e., on Saturday, 29th
October, 2022, in Business Standard (in English language) and .... | |
| |
| | Announcement under Regulation 30 (LODR)-Press Release / Media Release | 28/10/22 21:51 | Company Update | |
| | Astec LifeSciences Limited has informed the Exchange about the Board of Directors of the Company, at its Meeting held on Friday, 28th October, 2022, has approved the Unaudited Financial Results (both Standalone and Consolidated) as per Indian Accounting Standards (IND AS) for the Quarter and Half Year ended 30th September, 2022.
We enclose a copy of the Press Release and the same is being placed on the website of the Company, viz., www.astecls.com.
Please .... | |
| |
| | APPOINTMENT OF MR. MADHUR GUNDECHA AS THE 'CHIEF FINANCIAL OFFICER' OF THE COMPANY: | 28/10/22 16:49 | Company Update | |
| | The Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee, has appointed Mr. Madhur Gundecha as the 'Chief Financial Officer' of the Company with effect from 28th October, 2022. | |
| |
| | Announcement under Regulation 30 (LODR)-Meeting Updates | 28/10/22 16:46 | Company Update | |
| | The Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee, has appointed Mr. Madhur Gundecha as the 'Chief Financial Officer' of the Company with effect from 28th October, 2022. | |
| |
| | Unaudited Financial Results (Standalone And Consolidated) For The Quarter & Half Year Ended 30Th September, 2022 | 28/10/22 16:37 | Result | |
| | Please find attached outcome of Board Meeting held today, 28th October, 2022 | |
| |
| | Board Meeting Outcome for Board Meeting Outcome | 28/10/22 16:35 | Result | |
| | Please find attached outcome of Board Meeting held today, i.e. 28th October, 2022 | |
| |
| | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 27/10/22 11:45 | Company Update | |
| | Astec LifeSciences Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Conference Call to be held on Monday, 31st October, 2022 at 4.00 p.m. | |
| |
| | Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Friday, 28Th October, 2022 | 20/10/22 18:33 | Board Meeting | |
| | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), that the Meeting of the Board of Directors of Astec LifeSciences Limited ('the Company') is scheduled .... | |
| |
| | Reply On Significant Increase In The Volume Of Security Across Exchanges, In The Recent Past, Vide Your E-Mail Notice Bearing Ref. No.: L/SURV/ONL/PV/RS/ 2022-2023 /242 Dated 14Th October, 2022 | 14/10/22 12:41 | Company Update | |
| | Please find attached, our reply on significant increase in the volume of security across Exchanges, in the recent past, vide your E-mail Notice bearing Ref. No.: L/SURV/ONL/PV/RS/ 2022-2023 /242 dated 14th October, 2022. | |
| |
| | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 07/10/22 18:47 | Company Update | |
| | Please find enclosed herewith, compliance certificate received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of Astec LifeSciences Limited, for the Quarter ended 30th September, 2022, pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.
Please take the same on your records. | |
| |
| | Resignation Of Mr. Saurav Bhala As The 'Chief Financial Officer' Of The Company | 30/09/22 18:11 | Company Update | |
| | This is to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), Mr. Saurav Bhala has resigned as the 'Chief Financial Officer' (CFO) of Astec LifeSciences Limited ('the Company') with effect from the close of business hours on 30th September, 2022, in view of his decision to pursue a career opportunity outside the Company. .... | |
| |
| | Announcement under Regulation 30 (LODR)-Cessation | 30/09/22 18:09 | Company Update | |
| | This is to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), Mr. Saurav Bhala has resigned as the 'Chief Financial Officer' (CFO) of Astec LifeSciences Limited ('the Company') with effect from the close of business hours on 30th September, 2022, in view of his decision to pursue a career opportunity outside the Company. .... | |
| |
| | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | 30/09/22 18:00 | Company Update | |
| | This is to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), Mr. Saurav Bhala has resigned as the 'Chief Financial Officer' (CFO) of Astec LifeSciences Limited ('the Company') with effect from the close of business hours on 30th September, 2022, in view of his decision to pursue a career opportunity outside the Company. .... | |
| |
| | Closure of Trading Window | 29/09/22 19:24 | Insider Trading / SAST | |
| | This is to inform you that as per the Company's Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading)Regulations, 2015, the Trading Window for dealing in the securities of the Company will be closed
with effect from Saturday, 1st October, 2022 till 48 (forty-eight) hours after the declaration of the Unaudited Financial Results of the Company for the Quarter .... | |
| |
| | Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015) | 19/09/22 17:41 | AGM/EGM | |
| | Astec Lifesciences Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here | |
| |
| | Disclosure Of Voting Results Of Postal Ballot Pursuant To Regulation 44 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | 19/09/22 16:59 | AGM/EGM | |
| | In terms of Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith, the Voting Results on the Special business transacted through Postal Ballot Notice dated Monday, 25th July, 2022, along with the consolidated Scrutinizer''s Report on E-voting and Postal Ballot.
It may please be noted that as per the Report of the Scrutinizer dated Monday, 19th .... | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 17/08/22 14:29 | Company Update | |
| | In continuation to our intimations dated 25th July, 2022 and 16th August, 2022 and pursuant to Regulations 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of the newspaper advertisement published on Wednesday, 17th August, 2022, informing about the dispatch of the Postal Ballot Notice to the Members of Astec LifeSciences Limited. | |
| |
| | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | 16/08/22 22:50 | AGM/EGM | |
| | Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation dated Monday, 25th July, 2022, we are enclosing herewith, the Postal Ballot Notice together with Explanatory Statement, seeking approval of the Members for the Resolution as mentioned in the Postal Ballot Notice dated Monday, 25th July, 2022. | |
| |
| | Shareholder Meeting / Postal Ballot-Outcome of AGM | 26/07/22 16:16 | AGM/EGM | |
| | Please find attached outcome of 28th (Twenty Eighth) Annual General Meeting of the Company held on Monday, 25th July, 2022 along with the copy of the Scrutinizer''s report and Annual Report adopted by the Shareholders. | |
| |
| | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | 26/07/22 16:13 | AGM/EGM | |
| | Please find attached proceedings of 28th (Twenty Eighth) Annual General Meeting of the Company held on Monday, 25th July, 2022 along with the copy of the Scrutinizer''s report and Annual Report adopted by the Shareholders. | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 26/07/22 13:48 | Company Update | |
| | Pursuant to Regulation 30 read with Schedule III and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, copies of the newspaper publication of the Unaudited Financial Results for the Quarter ended 30th June, 2022, published by the Company today, i.e., on Tuesday, 26th July, 2022, in Business
Standard (in English language) and Mumbai Lakshadeep (in .... | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 21/07/22 19:22 | Company Update | |
| | Further to our letter dated 20th July, 2022, please find enclosed, Notices published in Business Standard (in English language) and Mumbai Lakshdeep (in Marathi language) on Thursday, 21st July, 2022, regarding transfer of Equity Shares of the Company in respect of which dividend has not been paid or claimed for 7 (Seven) consecutive years or more, to Investor Education and Protection Fund (IEPF), as per Section 124(6) of the Companies Act, 2013 .... | |
| |
| | Notice To Shareholders For Transfer Of Equity Shares To Investor Education And Protection Fund (IEPF) | 20/07/22 17:35 | Company Update | |
| | Pursuant to Regulation 30 read with Para A of Part A of Schedule III to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached, a specimen of the Notice dated 20th July, 2022 sent to the concerned Shareholders, at their latest available address(es) registered with the Company or the Registrar and Share Transfer Agents of the Company, viz., Bigshare Services Private Limited, .... | |
| |
| | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 16/07/22 18:42 | Company Update | |
| | Please find enclosed herewith, compliance certificate received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of Astec LifeSciences Limited, for the Quarter ended 30th June, 2022, pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.
Please take the same on your records. | |
| |
| | Board Meeting Intimation for Board Meeting Intimation For The Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Monday, 25Th July, 2022 | 16/07/22 13:39 | Board Meeting | |
| | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), that the Meeting of the Board of Directors of Astec LifeSciences Limited ('the Company') is scheduled .... | |
| |
| | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | 08/07/22 16:48 | Company Update | |
| | This is to inform you that the Nomination and Remuneration Committee of the Board of Directors of the Company, on 8th July, 2022, has approved allotment of Equity Shares to certain employees upon exercise of Options granted under Employees Stock Option Scheme, 2015 (ESOS 2015) and Employees Stock Option Plan, 2012 (ESOP 2012).
Please take the same on your records.
| |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 03/07/22 14:17 | Company Update | |
| | In continuation to our letter dated 2nd July, 2022 and pursuant to Regulations 47 and 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in connection with the 28th (Twenty Eighth)Annual General Meeting ('AGM') of Astec LifeSciences Limited ('the Company') scheduled to be held through VC / OAVM on Monday, 25th July, 2022 at 4.00 p.m. (IST), please find attached, .... | |
| |
| | Intimation Of Book Closure For The Purpose Of Dividend | 02/07/22 20:38 | Corp. Action | |
| | Pursuant to the Regulation 42 of the SEBI Listing Regulations, the Register of Members and the Share Transfer Books of the Company will remain closed for the purpose of the 28th (Twenty Eighth) AGM and payment of Final Dividend from Thursday, 21st July, 2022 to Sunday, 24th July, 2022 (both days inclusive). | |
| |
| | Astec Lifesciences Limited Has Informed The Exchange About Communication To Shareholders As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 About The 28Th (Twenty Eighth) Annual General Meeting ('AGM') Of The Company Scheduled To Be Held On Monday, 25Th July, 2022 At 4.00 P.M. (IST) Through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') | 02/07/22 20:29 | Company Update | |
| | In continuation to our letter dated 29th June, 2022 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('Company') for the Financial Year 2021-22, containing inter alia, the Notice of the 28th .... | |
| |
| | 28Th Annual General Meeting Scheduled To Be Held On Monday, 25Th July, 2022 At 4.00 P.M. Through Video Conferencing / Other Audio Visual Means | 02/07/22 20:20 | AGM/EGM | |
| | In continuation to our letter dated 29th June, 2022 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('Company') for the Financial Year 2021-22, containing inter alia, the Notice of the 28th .... | |
| |
| | Reg. 34 (1) Annual Report. | 02/07/22 20:12 | | |
| | In continuation to our letter dated 29th June, 2022 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('Company') for the Financial Year 2021-22, containing inter alia, the Notice of the 28th .... | |
| |
| | Reg. 34 (1) Annual Report. | 02/07/22 20:10 | | |
| | In continuation to our letter dated 29th June, 2022 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('Company') for the Financial Year 2021-22, containing inter alia, the Notice of the 28th .... | |
| |
| | Announcement under Regulation 30 (LODR)-Newspaper Publication | 29/06/22 21:12 | Company Update | |
| | Further to our intimation dated 2nd May, 2022 and in compliance with the provisions of the Companies Act, 2013 ('the Act'), the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') and MCA Circulars, Astec LifeSciences Limited ('the Company') has decided to hold its 28th (Twenty Eighth) AGM on Monday, 25th July, 2022 at 4.00 p.m. (IST) through VC / OAVM.
Pursuant .... | |
| |
| | Announcement under Regulation 30 (LODR)-Credit Rating | 24/06/22 19:34 | Company Update | |
| | Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the SEBI Regulations'), this is to inform you that we are in receipt of intimation letter from ICRA Limited ('ICRA') dated 23rd June, 2022, re-affirming / assigning the long-term rating of [ICRA]AA-' (pronounced 'ICRA double A minus') and the short term rating of '[ICRA]A1+' (pronounced .... | |
| |
| | Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | 14/06/22 14:39 | Result | |
| | Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 and the format specified under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November, 2021, please find enclosed herewith,
the disclosure of Related Party Transactions for the Half Year ended 31st March, 2022.
The above information is also being uploaded on the Company's website, viz., www.astecls.com. | |
| |
| | Astec Lifesciences Limited Has Informed The Exchange About The Disclosure Of Related Party Transaction For Half Year Ended 31St March, 2022, In The Format Prescribed Under SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2021/662 Dated 22Nd November, 2021 | 09/06/22 16:43 | Company Update | |
| | Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 and the format specified under SEBI Circular No.SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November, 2021, please find enclosed herewith,
the disclosure of Related Party Transactions for the Half Year ended 31st March, 2022.
The above information is also being uploaded on the Company's website, viz., .... | |
| |
| | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 25/05/22 12:55 | Company Update | |
| | This is to inform you under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') that Edelweiss has arranged a Meeting of Astec LifeSciences Limited with the Analysts and Investors on Wednesday, 25th May, 2022. | |
| |
| | Compliances-Reg.24(A)-Annual Secretarial Compliance | 24/05/22 17:16 | Company Update | |
| | In compliance with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed, the Annual Secretarial Compliance Report of Astec LifeSciences Limited ('the Company') for the Financial Year ended 31st March, 2022, issued by M/s. BNP & Associates, Company Secretaries | |
| |
| | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | 15/05/22 20:32 | | |
| | Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details | | 1 | Name of Company | ASTEC LIFESCIENCES LIMITED | | 2 | CIN NO. | L99999MH1994PLC076236 | ....| | | | | | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | 10/05/22 19:19 | Company Update | | | | Please find enclosed herewith transcript of Conference call of Astec LifeSciences Limited with the Investors and Analysts held on Tuesday, May 3, 2022 at 3.30 p.m. This aforementioned information is also made available on the website of the Company i.e., www.astecls.com
Kindly take note of the above. | | | | | | Intimation Of Grant Of Options Under Astec Lifesciences Limited - Employees Stock Option Plan, 2012 | 09/05/22 23:31 | Company Update | | | | Please find attached Intimation of Grant of Options under Astec LifeSciences Limited - Employees Stock Option Plan, 2012 | | | | | | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | 03/05/22 21:24 | Company Update | | | | Please note that the Audio Recording of Conference call of Astec LifeSciences Limited with the Investors and Analysts held today i.e. on Tuesday, May 3, 2022, is available / accessible at the website of the Company.
Kindly take the same on your records. | | | | | | Announcement under Regulation 30 (LODR)-Newspaper Publication | 03/05/22 21:22 | Company Update | | | | Please find enclosed, e-copies of the newspaper publication of the Audited Financial Results for the Quarter and Financial Year ended 31st March, 2022 (approved by the Board of Directors at its Meeting held on Monday, 2nd May, 2022, upon recommendation of the Audit Committee), published by the Company today i.e. on Tuesday, 3rd May, 2022 in Business Standard (in English language) and Mumbai Lakshdeep (in Marathi language). | | | | | | Announcement under Regulation 30 (LODR)-Press Release / Media Release | 02/05/22 19:18 | Company Update | | | | The Board of Directors of Astec LifeSciences Limited ('the Company'), at its Meeting held on Monday, 2nd May, 2022, has approved the Audited Financial Results (both Standalone and Consolidated) as per Indian Accounting Standards (IND AS) for the Quarter and Financial Year ended 31st March, 2022.
We enclose a copy of the Press Release and the same is being placed on the website of the Company, i.e., www.astecls.com.
Please take the above information on your records. | | | | | | Announcement under Regulation 30 (LODR)-Cessation | 02/05/22 18:36 | Company Update | | | | The Board of Astec LifeSciences Limited has noted the resignation of Mr. Rakesh Dogra (DIN: 07334098) from the position of 'Non-Executive, Non-Independent Director' of the Company with effect from 2nd May, 2022, due to his personal engagements. | | | | | | Announcement under Regulation 30 (LODR)-Resignation of Director | 02/05/22 18:32 | Company Update | | | | The Board of Astec LifeSciences Limited, has noted the resignation of Mr. Rakesh Dogra (DIN: 07334098) from the position of 'Non-Executive, Non-Independent Director' of the Company with effect from 2nd May, 2022, due to his personal engagements. | | | | | | Announcement under Regulation 30 (LODR)-Change in Directorate | 02/05/22 18:28 | Company Update | | | | The Board of Astec LifeSciences Limited has noted the resignation of Mr. Rakesh Dogra (DIN: 07334098) from the position of 'Non-Executive, Non-Independent Director' of the Company with effect from 2nd May, 2022. | | | | | | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | 02/05/22 18:17 | Company Update | | | | The Board of Directors of Astec LifeSciences Limited, based on the recommendation of the Audit Committee, has granted its approval for re-appointment of M/s. B S R & Co. LLP, Chartered Accountants as the 'Statutory Auditors' of the Company for a further term of 5 (Five) years commencing from the Financial Year 2022-23 upto the Financial Year 2026-27 (i.e., to hold office from the conclusion of the 28th (Twenty Eighth) Annual General Meeting till .... | | | |
|
| |
Archives |
<< Previous | Next >>
|
|
<< Back To Announcements
|